Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program

Last updated: March 21, 2023
Sponsor: VA Eastern Colorado Health Care System
Overall Status: Completed

Phase

N/A

Condition

Heart Failure

Congestive Heart Failure

Hyponatremia

Treatment

N/A

Clinical Study ID

NCT04281849
19-1783
1R03AG064371-01
  • Ages 55-100
  • All Genders

Study Summary

This is a pilot randomized trial of the BAMS-HF (Balance, Aerobic capacity, Mobility and Strength in patients hospitalized for Heart Failure) Program versus usual care. The BAMS-HF Program pilot study is an initial step in eventually creating a comprehensive, patient-centered, primarily home-based rehabilitation intervention aimed at preventing worsening disability and dependence among older adults hospitalized for HF. The BAMS-HF Program will enroll patients hospitalized for HF (or with HF as an active problem during hospitalization) within the past 4 weeks and will engage patients during the vulnerable post-discharged period. The objective of this pilot study is to test the feasibility, acceptability and preliminary effect of the BAMS-HF Program in older (>/= 65 years) adults hospitalized for HF. The BAMS-HF Program will begin within 4 week of hospital discharge and be administered 3 times weekly for 12 weeks in the patient's home upon discharge. Patients who are able to safely complete the program without in-person assistance will transition to telehealth (aka telerehabilitation) visits. The BAMS-HF Program is innovative because it is home-based, and will utilize rigorous, progressive exercises across multiple domains of physical function. The estimated preliminary effect size will be measured with the Short Physical Performance Battery (SPPB), a well-validated measure that predicts incident mobility/disability and falls in the geriatric population.

Aim #1: To assess the feasibility of the BAMS-HF Program by measuring 1) study enrollment rate, 2) proportion of prescribed sessions that were actually performed, 3) proportion of patients completing full baseline assessment and outcome measures

Aim #2: To assess the acceptability of the BAMS-HF Program with qualitative interviews of participants in the intervention arm that will ask about their experience in the program, any aspects of the intervention they recommend changing and whether patients would recommend the program to others. Reason for declining or stopping participation in the study will also be recorded and considered in adjusting the study protocol.

Aim #3: To estimate the preliminary intervention effect by investigating the difference in change in SPPB between the BAMS-HF Program arm and the usual care arm.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 55 years old or older
  • Hospitalized for HF or with HF as an active problem during hospitalization
  • SPPB >/=10

Exclusion

Exclusion Criteria:

  • Irreversible orthopedic or neurologic disease that severely limits mobility
  • Active cancer diagnosis except non-melanoma skin cancer
  • Dementia
  • Life expectancy of < 6 months
  • Uncontrolled/untreated ventricular tachycardia or ventricular fibrillation
  • Advanced heart failure with expectation of left ventricular assist device ortransplant in the next 6 months
  • Any major surgery in the past 30 days or planned in the next 10 weeks
  • Discharge to a skilled nursing facility and/or home with home healthcare physicaltherapy (home health care nurse or occupational therapist is ok)

Study Design

Total Participants: 29
Study Start date:
June 15, 2020
Estimated Completion Date:
September 14, 2022

Connect with a study center

  • Rocky Mountain Regional VA Medical Center

    Aurora, Colorado 80045
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.